Stock Market & Financial News
HSBC downgrades AstraZeneca after key trial failure
HSBC has downgraded AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) to 'hold' from 'buy', arguing that a recent trial failure has removed the central pillar of its bull case and left a tougher path ahead. The bank cut its target price to 13,750p from 16,500p, implying limited upside.
HSBC Compass Minerals: Why I Think The Market Is Mispricing The Recovery
Compass Minerals International is rated Buy with a fair value range of $31–$36, reflecting 4–21% upside from current levels. Significant deleveraging, net leverage down from 4.6x to 2.7x, and S&P credit upgrade, positions CMP for multiple expansion. Salt cost normalization and Plant Nutrition margin gains are key forward catalysts; Salt's counter-cyclical cash flows enhance CMP's relative appeal.
CMPGY Ripple CEO says SEC suit nearly pushed company to shut down
Brad Garlinghouse's account shows how a token reserve can shape a company's room to survive a long regulatory fight.
Netflix stock has crashed ahead of earnings: a bargain or value trap?
Netflix stock has been in a sharp downtrend over the past 12 months, erasing billions of dollars in market capitalization. It dropped to $73 last week, about 45% below its all-time high.
NFLX 
VXUS: The Growth/Inflation Quadrant Framework Suggests Caution
The author assigns a "hold" rating to VXUS, projecting accelerated growth combined with persistent inflation in the second half of the year—an unfavorable scenario for global ex-US equities; The US accounts for 64% of global market cap (up from 42% in 2008), supported by earnings that exceed the rest of the world. US, Japan, Eurozone, and ex-US equities are trading above their historical P/E averages, only emerging markets appear to be at fair value.
VXUS 
Robinhood's Chainlink CCIP Choice Adds Infrastructure Weight To Its Layer-2 Bet
Robinhood's crypto strategy is becoming less about offering a few coins and more about owning infrastructure. Its decision to use Chainlink CCIP for its Layer-2 network adds another piece to that shift, especially as the
JP Morgan flags reassurance on China rules as it backs Prudential
JP Morgan has placed Prudential PLC (LSE:PRU) on positive catalyst watch ahead of its first-half results, expecting reassurance on the impact of a Chinese regulatory change. The broker reiterated its 'overweight' rating on the insurer ahead of results due on 26 August.
MGHL 
Greggs' summer trading faces heatwave hit, warns analyst
Greggs PLC (LSE:GRG) could face another summer trading slowdown as the UK's prolonged heatwave weighs on demand for its core hot products like sausage rolls and steak bakes, according to Jefferies, even though the broker still expects solid first-half profits. Ahead of interim results on 29 July, the FTSE 250-listed baker's pricing position is strong, the broker said, after a 4% increase at the start of the year.
GGGSF 
Bitcoin price nears Fidelity's power law support: Accumulation zone or missing catalyst?
Bitcoin is drifting toward Fidelity's power law support near $58k, a zone tied to past cycle lows, but Jurrien Timmer says a catalyst is still missing.
Bitcoin ETFs see net inflows as crypto markets decline 1-3% overnight
Institutional interest in Bitcoin ETFs amid market decline may signal confidence in long-term crypto stability despite short-term volatility. Bitcoin ETFs see net inflows as crypto markets decline 1-3% overnight.
Intuitive Surgical Has +35% Upside: A Compelling Buy Story Before July 16
Intuitive Surgical (NASDAQ:ISRG | ISRG Price Prediction) looks compelling ahead of its July 16 earnings report, and the setup rarely gets this clean for a category leader trading well below fair value.
ISRG 
Arbutus Biopharma: Moderna Validates My IP Bull Case
Arbutus Biopharma is now much better capitalized after Moderna validated the value of its LNP patents. As for ABUS' in-house assets, I think Imdusiran has shown durable viral control. The main caveat is that it comes from combo therapies. Their balance sheet gives them a comfortable runway to pursue imdusiran's upcoming Phase 2b trial, which is yet another optionality vertical for the stock.
MRNA 
SBI Holdings and Solana Forge Strategic Alliance to Build Japan's Onchain Financial Market
SBI Holdings and Solana Foundation announced a strategic collaboration to build an onchain financial market from Japan through SBI R3 Japan. SBI R3 Japan is expected to adopt the planned trade name SBI Solana Global and support JPYSC, tokenized RWAs, cross-border settlement, institutional services and AI-agent payments.
Where Fundamental Analysis Meets the Chartists: The Launch of Defiance's RANK ETF
In my former career as a stock research analyst, a unique dynamic always signaled a high-conviction idea. While I sat there building out earnings models and reworking valuation assumptions, the technical analysts would look for relative strength or weakness.
RANK 
Reactor Restarts Add New Layer to Nuclear Renaissance
The U.S. nuclear sector is moving beyond discussions about preserving existing reactor capacity.
CEG 
SK Hynix Makes its US Debut: Which ETFs Offer Exposure?
Friday, July 10, may have been ordinary for those outside the investment community, but for folks engaged with the market, it marked an opportunity to gain exposure to the second most valuable company in South Korea. On Friday, SK Hynix (SKHY) became available to U.S. investors via the Nasdaq.
EWY 
Here Are Monday's Best Wall Street Analyst Research Calls: Atmos Energy, Best Buy, Biogen, Capital One, Costco, Disney, Papa John's International, Shopify, and More
Futures are trading lower as we get ready for the start of second-quarter earnings this week, after a solid winning week on Wall Street.
BIIB 
Butler National: The Multi-Year Aerospace Growth Story Is Just Beginning
Butler National Corporation maintains a strong buy rating, driven by robust aerospace growth and margin expansion. Recent muted share price performance reflects sector rotation, cost inflation risks, and delayed NASDAQ uplisting catalysts. FY26 sales grew 17% to $98M, with aerospace up 33% and operating margin expanding from 20% to 29%.
BUKS 
Morning Minute: BTC and ETH ETFs Flip Green After Lengthy Outflow Stretch
U.S. spot Bitcoin ETFs closed their first positive week since May, but a big week ahead will likely determine crypto's near-term fate.
Ripple Joins BlackRock and J.P. Morgan to Tokenize UK Debt Worth £33 Billion
The UK Treasury has officially brought Ripple into a large-scale government reform aimed at tokenizing wholesale financial markets. The technology giant has joined a special working group of 54 participants established under the auspices of Wholesale Digital Markets Champion Chris Woolard and the City of London Corporation.
Gold Price Forecast: XAU/USD drifts below $4,100, but bears start to look exhausted
Gold Price Forecast: XAU/USD drifts below $4,100, but bears start to look exhausted
Nike: Iconic Brand But Wouldn't Touch It With A 10-Foot Pole Right Now
Nike remains a hold as persistent margin pressure and tepid revenue growth offset its iconic brand and near-4% dividend yield. NKE's recent double-beat earnings were inflated by a $986M one-time tariff refund; underlying EPS and margins declined, raising concerns about sustainable profitability. North America showed resilience, but declines in EMEA, APLA, and Greater China, plus flat FY'27 revenue guidance, limit near-term upside potential.
NKE 
Hyperliquid's real-world asset markets hit record $4B open interest
Hyperliquid's growth in tokenized assets signals a shift towards decentralized finance, potentially reshaping traditional market dynamics. Hyperliquid's real-world asset markets hit record $4B open interest.
Bitcoin Dips on Monday Morning Shockwave; XRP Breaks Below Key $1.10 Level
Bitcoin fell from above $64,300 at the weekly close to around $63,100, briefly touching $62,400 before rebounding above $63,000 on Monday. Renewed U.S.-Iran hostilities, equity weakness and profit-taking hit sentiment, while XRP broke below $1.10 and ETH failed at $1,800.
Is Disney or PayPal the Better Rebound Play Now?
Walt Disney (NYSE:DIS | DIS Price Prediction) and PayPal (NASDAQ:PYPL) are both trading well below their multi-year highs, attracting income-oriented investors hunting for a rebound.
PYPL 
Diageo needs plausible and sustainable profit reset to rebuild confidence, says Deutsche Bank
Diageo PLC (LSE:DGE) faces growing pressure to reset investor expectations when it reports annual results next month, with Deutsche Bank arguing the drinks group needs a more realistic profit base before it can return to consistent growth. The bank maintained its 'buy' rating but cut its target price to 1,700p from 1,759p ahead of the company's results and strategy update on 6 August.
DEO 
UBS stays positive on AstraZeneca ahead of second-quarter results
UBS expects AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) to report solid second-quarter results later this month, though it sees little room for the drugmaker to raise full-year guidance. The bank reiterated its 'buy' rating on Britain's second most valuable listed company, ahead of results due on 27 July.
UBS 
BNB Chain's AWS-Linked Agent Studio Pushes AI Back Into The Crypto Infrastructure Race
The AI-agent narrative in crypto has gone through plenty of hype, but BNB Chain is trying to move the discussion toward tooling. Its new Agent Studio roadmap, built around developer templates and AWS-linked infrastructur
Bitcoin whale moves $188M for first time in 7 years
A dormant whale transferred BTC worth $188 million after seven years of holding, adding to the growing ratio of whale transfers to cryptocurrency exchanges.
Ripple supports UK tokenization strategy, potential £33B boost by 2035
Ripple's support for UK tokenization could enhance digital asset adoption, positioning the UK as a leader in financial innovation. Ripple supports UK tokenization strategy, potential £33B boost by 2035.
